分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Sub1 contributes to heart failure with preserved ejection fraction driven by aging in mice

Di Zhao, Ling Lin, Yufei Zhou, Jiaying Wu, Ran Xu, Linnan Li, Xiaoxue Zhang, Hong Lin, Jienan Wang, Kunming Dai, Zhiwen Ding, Pan Gao, Jian Wu, Yunzeng Zou

Journal:Nature Communications

IF:18.1

DOI:10.1038/s41467-026-75237-9

PMID:42402618

Published:2026-07-06

research field:分子生物学基因治疗生物技术

Abstract

Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure cases and predominantly affects older individuals, yet effective treatments remain limited. The molecular mechanisms linking cardiac aging to HFpEF are not fully understood. Here we show that the transcriptional regulator Sub1 is upregulated in aged hearts and in mouse models of HFpEF. Cardiac overexpression of Sub1 shortens lifespan, exacerbates diastolic dysfunction, and accelerates cardiac aging, whereas Sub1 knockdown delays cardiac aging and alleviates HFpEF features, even when initiated in aged mice. Mechanistically, Sub1 interacted with TAF9b and AROS to stabilize p53 by regulating its ubiquitination and acetylation, thereby promoting cardiomyocyte senescence. Furthermore, disrupting the Sub1–p53 interaction attenuates cardiomyocyte senescence in vitro. These findings identify Sub1 as a contributor to aging-associated HFpEF and provide insight into the molecular links between cardiac aging and disease progression. Heart failure with preserved ejection fraction (HFpEF) predominantly affects older individuals. Here the authors report that the transcriptional regulator Sub1 promotes age-related HFpEF in mice, potentially via stabilizing p53 and subsequent cardiomyocyte senescence.

本文使用的Yeasen产品

购物车
客服
转染试用